Press Releases

Month Year

Month Year

Apr 25, 2018

Insmed to Host First Quarter 2018 Financial Results Conference Call on Wednesday, May 2, 2018

Read more
Mar 29, 2018

Insmed Submits New Drug Application to FDA for ALIS in NTM Lung Disease Caused by MAC

ALIS previously designated as an orphan drug, breakthrough therapy and Qualified Infectious Disease Product (QIDP)

Read more
Mar 7, 2018

Insmed to Present at the Cowen and Company 38th Annual Health Care Conference

Read more
Feb 23, 2018

Insmed Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

On track to file NDA before the end of March and anticipate a priority review

Read more
Feb 21, 2018

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more
Feb 20, 2018

Insmed Extends ALIS Intellectual Property Protection to 2035 with Issuance of Ninth U.S. Patent

Read more
Feb 15, 2018

Insmed to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call on Friday, February 23, 2018

Read more
Feb 7, 2018

Insmed to Present at the Leerink Partners 7th Annual Global Healthcare Conference

Read more
Jan 26, 2018

Insmed Announces Closing of Public Offering

Read more
Jan 24, 2018

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your email alerts.

Investor Presentation

View the latest Insmed Investor Presentation